# Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

> **NCT00023829** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 67 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** flutamide
- **DRUG:** releasing hormone agonist therapy
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00023829
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00023829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00023829, "Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00023829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*